An interventional study of Forest Therapy Group and Standard Care (in control arm) in Postpartum Depression, Postpartum Depression (PPD) and Postnatal Depression, sponsored by Hong Kong Baptist University. Enrolling by invitation at 1 site in China. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Hong Kong Baptist University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Depression, Postpartum with a site in China — 10 open to participants now, 11 under way, 1 of them phase 3. Depression, Postpartum · China.
Among the 21 studies in Depression, Postpartum with a site in China, this one is the 18th largest by planned enrollment of the 18 interventional ones that give a count, is one of 6 that started in 2026, is one of 10 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 21st registered.
569 studies on the registry are indexed under Depression, Postpartum; 134 are open to participants now.
Browse Depression, Postpartum studies →10 of the 21 studies in Depression, Postpartum with a site in China are open now. Recruiting first, the newest first:
Nanjing Minova Pharmaceutical Co., Ltd. · Sites in China
Ages 18–45 · Women only
Xi Huang · Sites in China
Ages 18–50 · Women only · Healthy volunteers
Huazhong University of Science and Technology · Sites in China
Ages 20–50 · Women only
Women's Hospital School Of Medicine Zhejiang University · Sites in China
Ages 18+ · Women only
Huazhong University of Science and Technology · Sites in China
Ages 18+ · Women only · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 87 Depression, Postpartum studies recruiting now, 54 (62%) set no upper age limit and 30 (34%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 2 · Phase 4 4
First in 2005; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 104 across 454 interventional studies indexed under Depression, Postpartum.
Median enrollment 237 across the 18 interventional studies, 330 across the 3 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 21 have an industry lead sponsor. The 10 most frequent:
Hong Kong Baptist University is the lead sponsor of 85 studies on the registry; 24 are open to participants now.
Hong Kong Baptist University has 1 study filed under Depression, Postpartum — fewer than ten, so there is no comparison to draw.
4 of the studies in Depression, Postpartum with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06704490Huazhong University of Science and TechnologyAnalysis of the Incidence and Risk Factors of Chronic Pain After Cesarean Section | 2026-12-31 |
| NCT07501728Chengdu Jinjiang Maternity and Child Health HospitalIntranasal Dexmedetomidine for Postpartum Depression Prevention | 2027-01-01 |
| NCT07943858Hong Kong Baptist UniversityCan Spending Time in Nature Help Mothers With Depression After Childbirth? A 6-Week Forest Therapy Study | 2027-05-20 |
| NCT07807462The First People's Hospital of LianyungangEffect of Peripartum 40 Hz Audiovisual Stimulation on Postpartum Depression in Women Undergoing Elective Cesarean Section: A Randomized Clinical Trial | 2027-05-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 21 studies in Depression, Postpartum with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to test a 6-week nature-based program called "Forest for Mothers" to help women with mild-to-moderate postpartum depression (PPD). PPD is common, but current treatments can be hard to access or may not be safe for breastfeeding mothers. We are testing whether spending time in nature in a group setting can improve mood and well-being.
We will recruit 40 mothers who gave birth within the last 3 years and have mild-to-moderate depressive symptoms. Participants will be randomly assigned to either a forest therapy group or a standard care group. The forest therapy group will attend weekly 2-hour guided sessions in an urban forest park for 6 weeks. These sessions include gentle walking, sensory exercises, meditation, group sharing, and nature-based creative activities. The standard care group will receive an information booklet on postpartum depression management.
All participants will complete questionnaires about their mood, stress, sleep, and quality of life at the start of the study, after 6 weeks, and at 3- and 6-month follow-ups. We hope to find that this nature-based program is an effective, accessible, and safe non-drug option to help mothers feel better.
This study aims to develop and test a nature-based intervention (Forest for Mothers, FfM) for postpartum depression (PPD). PPD affects 15-20% of mothers globally, but current treatments face limitations in accessibility, cost, and medication safety during lactation.
The study consists a definitive, assessor-blinded, randomized controlled trial (RCT) to test the efficacy of a standardized 6-week forest therapy intervention.
Participants (N=40) will be recruited from community health centers and maternity hospitals in Shanghai, China. Eligible participants are women within 36 months postpartum, aged 18 or above, with an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 10, indicating mild-to-moderate depression. Exclusion criteria include severe mental illness or active suicidal ideation.
The intervention group will receive the 6-week forest therapy program plus standard care, while the control group will receive standard care alone (including an information booklet). The program consists of weekly 120-minute sessions in urban forest parks, facilitated by a trained social worker/psychologist and an assistant. Sessions include sensory exercises, mindful walking, guided meditation, group sharing, and nature-based creative activities. Childcare support will be provided on-site.
Outcome assessments will be conducted at baseline, post-intervention (week 6), 3-month, and 6-month follow-ups. The primary outcome is the change in depressive symptoms measured by the EPDS. Secondary outcomes include anxiety (GAD-7), perceived stress (PSS), quality of life (WHOQOL-BREF), sleep quality (PSQI), and heart rate variability (HRV). A subset of participants will be invited to an audio-recorded semi-structured interview to explore their experiences, perceived benefits, and challenges.
Safety protocols include on-site first aid kits, facilitators trained in basic first aid, a licensed mental health professional on the research team, emergency contingency plans, and a referral pathway for community mental health services. Participants may pause or stop participation at any time.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive standard care plus a 6-week forest therapy program (one 120-minute session per week in an urban forest park). Sessions include sensory exercises, mindful walking, guided meditation, group sharing, and nature-based creative activities.
Behavioral: Forest Therapy Group
Participants receive information on postpartum depression management.
Behavioral: Standard Care (in control arm)
A standardized 6-week forest therapy program called "Forest for Mothers" (FfM). Participants attend one 120-minute session per week in an urban forest park, guided by a trained facilitator (social worker or psychologist) and an assistant. Sessions include sensory exercises, mindful walking, guided meditation, group sharing, and nature-based creative activities. The program also includes weekly "nature homework" (e.g., a one-minute nature pause). Childcare support is provided on-site during sessions.
Offering participants information about postpartum depression management.
Change in Depressive Symptoms (EPDS Score)
The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire used to assess depressive symptoms. Scores range from 0 to 30, with higher scores indicating more severe depressive symptoms. The primary outcome is the change in EPDS score from baseline to post-intervention (Week 6).
Time frame: Baseline, Week 6, 3-month, and 6-month follow-ups
Change in Anxiety Symptoms (GAD-7 Score)
The Generalized Anxiety Disorder 7-item (GAD-7) scale. Scores range from 0 to 21, with higher scores indicating more severe anxiety symptoms.
Time frame: Baseline, Week 3-month, and 6-month follow-ups
Change in Perceived Stress (PSS Score)
The 10-item Perceived Stress Scale (PSS). Scores range from 0 to 40, with higher scores indicating higher levels of perceived stress.
Time frame: Baseline, Week 6
Change in Quality of Life (WHOQOL-BREF Score)
The World Health Organization Quality of Life-Brief Version (WHOQOL-BREF). This 26-item questionnaire assesses physical health, psychological health, social relationships, and environment. Higher scores indicate better quality of life.
Time frame: Baseline, Week 6
Change in Sleep Quality (PSQI Score)
The Pittsburgh Sleep Quality Index (PSQI). Scores range from 0 to 21, with higher scores indicating worse sleep quality.
Time frame: Baseline, Week 6
Change in Heart Rate Variability (HRV)
Heart rate variability will be measured using a small, non-invasive wearable monitor (similar to a smartwatch) worn by participants to assess physiological stress response.
Time frame: Baseline, Week 6
Participants' Experiences and Perceived Benefits
Semi-structured audio-recorded interviews will be conducted with a subset of participants (approximately 10-15 from the intervention group) to explore their experiences, perceived benefits, challenges, and suggestions for the "Forest for Mothers" program.
Time frame: Post-intervention (Week 6)
Plan to share: No — Individual participant data (IPD) will not be shared. This is a small-scale doctoral study (N=40) involving sensitive mental health data (including postpartum depression questionnaires and audio-recorded interviews). Sharing raw IPD would pose risks to participant privacy and confidentiality. Additionally, the study team does not have the resources or institutional infrastructure to establish a formal data-sharing repository.
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for May 2027, 7 months after the start.
Of 257 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 7 months is below that.
Counting every sponsor, half of 263 studies reached it within 23 months; a quarter within 11 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hong Kong Baptist University